Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,782,177
  • Shares Outstanding, K 105,736
  • Annual Sales, $ 138,290 K
  • Annual Income, $ -140,850 K
  • 60-Month Beta 1.41
  • Price/Sales 25.14
  • Price/Cash Flow N/A
  • Price/Book 7.67
Trade ARWR with:

Options Overview Details

View History
  • Implied Volatility 76.75% ( +3.30%)
  • Historical Volatility 87.90%
  • IV Percentile 90%
  • IV Rank 47.65%
  • IV High 107.57% on 05/11/22
  • IV Low 48.70% on 10/20/21
  • Put/Call Vol Ratio 0.47
  • Today's Volume 903
  • Volume Avg (30-Day) 340
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 22,060
  • Open Int (30-Day) 19,771

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.48
  • Number of Estimates 6
  • High Estimate 0.26
  • Low Estimate -0.72
  • Prior Year -0.29
  • Growth Rate Est. (year over year) -65.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.87 +22.71%
on 05/12/22
47.20 -27.54%
on 04/21/22
-10.13 (-22.85%)
since 04/18/22
3-Month
27.87 +22.71%
on 05/12/22
51.11 -33.09%
on 04/05/22
-10.05 (-22.71%)
since 02/18/22
52-Week
27.87 +22.71%
on 05/12/22
93.66 -63.48%
on 06/23/21
-38.06 (-52.67%)
since 05/18/21

Most Recent Stories

More News
Arrowhead Pharmaceuticals (ARWR) Q2 2022 Earnings Call Transcript

ARWR earnings call for the period ending March 31, 2022.

ARWR : 34.20 (-4.39%)
Arrowhead Pharmaceuticals Reports Fiscal 2022 Second Quarter Results

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal second quarter ended March 31, 2022. The company is hosting a conference call today, May 10, 2022, at 4:30...

ARWR : 34.20 (-4.39%)
Arrowhead Breaks Ground on New Manufacturing Facility with Wisconsin Governor Tony Evers and Announces Receipt of Incentives

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today held a groundbreaking ceremony in Verona, WI, on the site which will house a new approximately 160,000 square foot drug manufacturing facility and an...

ARWR : 34.20 (-4.39%)
Arrowhead Pharmaceuticals Appoints Victoria Vakiener to Board of Directors

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran pharmaceutical industry executive Victoria Vakiener, as an independent director of the company,...

ARWR : 34.20 (-4.39%)
Arrowhead Pharmaceuticals to Participate in Upcoming May 2022 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 34.20 (-4.39%)
Arrowhead Pharmaceuticals to Host Pulmonary R&D Day

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a pulmonary research & development (R&D) day to discuss its emerging pipeline of pulmonary targeted RNA interference (RNAi)...

ARWR : 34.20 (-4.39%)
Arrowhead Pharmaceuticals Initiates Phase 2 GATEWAY Study of Investigational ARO-ANG3 for Treatment of Homozygous Familial Hypercholesterolemia

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first patients in the Phase 2 GATEWAY clinical study of investigational ARO-ANG3 for the treatment of patients with homozygous...

ARWR : 34.20 (-4.39%)
Arrowhead Pharmaceuticals to Webcast Fiscal 2022 Second Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 10, 2022, at 4:30 p.m. ET to discuss its financial results for the fiscal 2022 second...

ARWR : 34.20 (-4.39%)
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on April 1, 2022, the Compensation Committee of the Company’s Board...

ARWR : 34.20 (-4.39%)
Arrowhead Pharmaceuticals to Participate in Upcoming April 2022 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 34.20 (-4.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

3rd Resistance Point 37.59
2nd Resistance Point 36.87
1st Resistance Point 35.53
Last Price 34.20
1st Support Level 33.47
2nd Support Level 32.75
3rd Support Level 31.41

See More

52-Week High 93.66
Fibonacci 61.8% 68.53
Fibonacci 50% 60.77
Fibonacci 38.2% 53.00
Last Price 34.20
52-Week Low 27.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar